The DpT class of agents has been demonstrated by several international laboratories to possess potent and selective anti-tumor activity against a broad range of tumors in vitro and in vivo, with the compounds also being able to overcome P-glycoprotein-mediated resistance [6,7,10,11,12,13,14]. This evidence concerns the gene ABCB1 and neoplasm.